| Specialty Retail Industry | Consumer Discretionary Sector | Sang-Jun Lee CEO | KRX SM Exchange | KR7004310009 ISIN |
| KR Country | - Employees | - Last Dividend | 17 Mar 2008 Last Split | - IPO Date |
Founded in 1965, Hyundai Pharmaceutical Co., Ltd. is a distinguished entity in the pharmaceutical industry, based in Seoul, South Korea. The company has carved a niche for itself both domestically and internationally by manufacturing and distributing a wide array of pharmaceutical products, health food drinks, and medical devices. Its commitment to improving health and enriching lives through innovative and effective products is evident in its diverse product range. Hyundai Pharmaceutical operates in the pharmaceutical sector with a keen focus on producing both ETC (Ethical Pharmaceutical Products) and OTC (Over The Counter) products across various therapeutic areas. Their mission encapsulates delivering health solutions that are not only accessible but also of the highest quality, catering to a spectrum of health needs and contributing to the global healthcare industry.
Hyundai Pharmaceutical specializes in a vast range of prescription (ETC) and over-the-counter (OTC) products focused on numerous therapeutic fields. These include cardiovascular health (antianginal, antihypertensive), infection control (antibiotic, antifungals), gastrointestinal health (digestive system, gastrointestinal disorder and digestant), reproductive health (oestrogens, systemic hormonal contraceptives), dermatology (dermatological agent, acne treatment), and nutritional supplements (vitamins, nutrition). Each product category is developed with precise formulations to address specific health concerns efficiently.
The company offers a range of health food drinks aimed at enhancing overall health. These drinks are formulated with natural ingredients known for their health benefits, targeting areas such as immune system boosting, energy enhancement, and nutritional supplementation. Hyundai’s health beverages are designed not only to complement the consumer’s diet but also to support a healthy lifestyle.
Hyundai Pharmaceutical extends its contribution to healthcare through the provision of medical devices. These devices cater to diverse medical needs, including diagnostic tools, health monitoring devices, and other therapeutic products. Each device is engineered with the latest technology to ensure reliability, accuracy, and ease of use, supporting both healthcare professionals and patients in managing health more effectively.
The company’s portfolio spans a broad spectrum of therapeutic areas, offering solutions for anemia, alopecia treatment, allergy relief, analgesics, anti-inflammatory, antimicrobial, antiviral, arthritis care, contraceptives, dermatology, diagnostics, eye care, nutrition, respiratory care, wound healing, and more. Hyundai Pharmaceutical is committed to advancing healthcare through the development of products that cater to a wide range of medical conditions, aiming to improve the quality of life for patients around the globe.